U.S. authorizes Regeneron's COVID-19 antibody therapy for injection | Reuters

U.S. authorizes Regeneron's COVID-19 antibody therapy for injection | Reuters: The U.S. health regulator authorized a lower dose of Regeneron Pharmaceutical's COVID-19 antibody cocktail that can be given by injection, a move that could ease logistical challenges stemming from administering a higher dose intravenously.